Patents by Inventor José Mª Jimeno Donaque

José Mª Jimeno Donaque has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110015135
    Abstract: The present invention relates to combinations of PM02734 with another anticancer drug selected from Cisplatin, Gemcitabine, Paclitaxel, Oxaliplatin, 5-Fluorouracil, Trabectedin, Rapamycin, and Sunitinib, and the use of these combinations in the treatment of cancer.
    Type: Application
    Filed: March 6, 2009
    Publication date: January 20, 2011
    Applicant: Pharma Mar S.A.
    Inventors: Santiago Ramón Y Cajal Agüeras, Javier Hernández Losa, José Mª Jimeno Doñaque, Eric Raymond
  • Publication number: 20100267732
    Abstract: The present invention relates to the use of ecteinascidin 743 in human patients having certain molecular markers profile which has been associated with the outcome of ET-743 chemotherapy. In particular, the invention relates to the use of ecteinascidin 743 in patients having high expression levels of XPG mRNA or protein and/or having a “wild type” genotype for Asp1104His SNP of XPG gene.
    Type: Application
    Filed: October 20, 2008
    Publication date: October 21, 2010
    Applicant: PHARMA MAR, S.A.
    Inventors: Rafael Rosell Costa, Miguel Tarón Roca, Nerea Martínez Magunacelaya, Ana Díez Rodríguez, José Mª Jimeno Donaque, Juan Carlos Tercero López